Stockreport

VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors

VYNE Therapeutics Inc.  (VYNE) 
PDF BRIDGEWATER, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company develo [Read more]